Quality & Compliance

Compliance Embedded from

Day One of Cultivation

Our quality framework is not a post-production layer. Every protocol — from seed selection to shipment documentation — is designed around the standards pharmaceutical buyers require before they place a purchase order.

NACOC

kg Annual Pilot Capacity

GACP

Global Market by 2030

ALCOA+

Prior Licensed Suppliers
in West Africa

EU-GMP

Prior Licensed Suppliers
in West Africa

Core Credentials

Regulatory & Quality Framework

First-mover positioning under a purpose-built regulatory framework, backed by scientific infrastructure and a team built for pharmaceutical markets.

Active — February 2026

NACOC Licence — LI 2475

Hemp Medicinal Farm Ltd holds a licence under Ghana’s Narcotic Control Commission Act 1100 and Licensing Instrument LI 2475, the first formal pharmaceutical cannabis regulatory framework in West Africa, activated February 2026. This positions HMF Ltd as one of a small number of legal pharmaceutical cannabis producers on the continent.

— Production, processing, and export authorisation
— Compliance reporting to NACOC on defined schedule
— Batch-level documentation submitted to regulator
— Security, storage, and chain-of-custody requirements met
— Renewable licence subject to ongoing compliance review

Phase 1 Active

GACP Framework

Good Agricultural and Collection Practices implementation covering all cultivation, harvesting, and post-harvest handling operations.


— Controlled environment agriculture protocols

— Standardised cultivation SOPs

— Documented quality control at every stage requirements met

— Full seed-to-harvest traceability

— Personnel training and qualification records

ISO 17025-Adjacent

Analytical Laboratory

In-development analytical testing capabilities with current third-party testing partnerships for full batch verification.


— Cannabinoid profile analysis (HPLC validated)

— Terpene quantification

— Heavy metals — ICH Q3D / EU MRL compliant

— Microbial contamination per USP/Ph. Eur.

— Pesticide residue analysis

In Development

QMS Framework

Pharmaceutical-grade Quality Management System covering document control, deviation management, CAPA, change control, customer complaints, and full equipment and process validation.

— Document control and version management

— Deviation and non-conformance reporting

— Corrective and Preventive Action (CAPA) system

— Validation and qualification of equipment, tools, processes, and rooms (IQ/OQ/PQ)

— Internal audit programme

Our Approach

"Compliance Is Embedded in Our Methodology — Not Layered on After Production."

From the first cultivation decision to the final shipment document, every step at HMF Ltd is designed around the raw material requirements of regulated pharmaceutical supply chains.

Testing Protocols

Batch Testing Parameters & Specifications

Every batch of pharmaceutical-grade dried flower undergoes comprehensive testing. Results are included in the full documentation package provided with each shipment.

Cannabinoid Profile

THC Content

< 0.2% (EU Compliant Strains)

THC (High-THC strains)

15–28%

CBD Content

0.5–15% (strain dependent)

Minor Cannabinoids

CBG, CBC, CBN

Total Cannabinoids

15–20%

Method

HPLC (Ph. Eur. validated)

Terpene Analysis

Myrcene

Quantified per batch

Limonene

Quantified per batch

Pinene

Quantified per batch

Linalool

Quantified per batch

Total Terpenes

1–3%

Method

GC-FID / GC-MS

Contaminant Screening

Heavy Metals

Below EU MRLs / ICH Q3D

Pesticide Residues

Below EU MRLs

Microbial Load

< 1,000 CFU/g

Aflatoxins

< 4 ppb

Residual Solvents

< 5,000 ppm (Ph. Eur.)

Water Activity

≤ 0.65 Aw

Physical Specifications

Moisture Content

< 12%

Shelf Life

24 months (per storage spec)

Storage Temperature

18–22°C

Storage Humidity

55–62% RH

Minimum Order

25 kg per batch

Documentation

COA, Batch Record, Regulatory Package

NACOC Licensed

West Africa's First Licensed Producer

Ghana’s NACOC Act 1100 and LI 2475 created the first formal pharmaceutical cannabis regulatory framework in the region. HMF Ltd is among the inaugural licence holders.


— Licence granted February 2026 under LI 2475

— Compliance reporting to NACOC on defined schedule

— Full batch-level documentation submitted to regulator

— Security, storage, and chain-of-custody requirements met

Quality Assurance at Every Stage

GACP/GMP Applied

Seed to Shipment

Quality Assurance & Compliance is not a final checkpoint at HMF Ltd — it is embedded into every stage of production, from the first seed to the final shipment document.

STAGE 01

Genetics & Seed Selection

Verified cultivar identity and genetic documentation
Phytosanitary certificates on all incoming material
Pre-cultivation phenotype profile records

GACP · NACOC Licence

STAGE 02

Cultivation & Growing

Environmental monitoring — temperature, humidity, CO₂
Integrated Pest Management (IPM) documentation
Nutrient management and irrigation records
Daily growth inspection logs
Validation & qualification of cultivation equipment and rooms

GACP Phase 1 · SOPs Active

STAGE 03

Harvest & Post-Harvest Handling

Batch number assigned at point of harvest
Harvest weight and yield documented per batch
Chain of custody initiated — ALCOA+ from this point
Contamination prevention protocols activated

GACP · ALCOA+ Initiated

STAGE 04

Drying, Curing & Processing

Controlled drying: 18–22°C, 55–62% RH, continuous monitoring
Moisture content verified — target <12%
Validation & qualification of drying rooms and processing tools
Cold extraction system: eliminates thermal processing — preserving cannabinoids & terpenes from thermal decomposition

GMP Principles · Process Validation

STAGE 05

Analytical Testing

Cannabinoid profile — HPLC validated (THC, CBD, CBG, CBC, CBN)
Terpene quantification — GC-FID / GC-MS
Heavy metals — ICH Q3D / EU MRL compliant
Microbial contamination — USP / Ph. Eur. limits
Pesticide residues — EU MRLs · Aflatoxins — <4 ppb

GMP · Third-Party Tested · COA Issued

STAGE 06

Quality Review & Release

Batch record review — all ALCOA+ documentation verified
Deviation and non-conformance review
Customer complaints register checked — no open issues
Qualified Person (QP) batch release authorisation
Certificate of Analysis (COA) finalised and signed

QMS · ALCOA+ · Batch Release

STAGE 07

Packaging, Storage & Shipment

Multi-layer barrier packaging — nitrogen purged, tamper-evident
Cold chain management — validated 18–22°C transit ≤72 hours
NACOC export authorisation documentation
Full documentation package: COA, batch records, regulatory compliance
Destination import authorisation confirmed (EU / Canada)

GMP · NACOC Export · ALCOA+ Complete

Data Integrity

ALCOA+ Data Integrity Standard

All data and documentation at HMF Ltd is maintained to ALCOA+ principles — the gold standard for pharmaceutical data integrity, accepted by all major regulatory authorities.

A

Attributable

Every data entry is linked to the person who recorded it, with date and time stamps. No anonymous entries. Complete personnel accountability throughout the production record.

L

Legible

All records are permanently recorded in ink or digital systems. Corrections are made with a single strike-through, initialled and dated — never obscured or overwritten.

C

Contemporaneous

Data is recorded at the time of the activity, not reconstructed afterward. Real-time recording is a non-negotiable operational standard enforced through SOPs and training.

O

Original

The first record of an observation is preserved. Copies and reproductions are marked as such. Original data is never discarded, even when transcription to other systems occurs.

A+

Accurate & Complete

Data reflects the actual observations and measurements made. No selective recording. All results — whether passing or failing — are documented and retained in the permanent batch record.

Investor Perspective

ALCOA+ compliance means pharmaceutical buyers can rely on HMF documentation during their supplier qualification audits. This is what makes a supply relationship bankable for regulated manufacturers.

Request the Due Diligence Package

Qualified pharmaceutical partners and investors can access our full compliance documentation on request.